PAVM · PAVmed Inc
United States · RS rating 4 · As of 2026-11-03
| Price | 1.82 USD |
|---|---|
| 1-day change | -4.7% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 11 / 5 / 7 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 5 / 13 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -606.9% |
| Sales growth Q/Q | +940.0% |
| Distance from 52-week high | +84.9% |
| Market cap (USD) | $57.9M |